Skip to main content

A Comparison of Sustained-release Bupropion and Placebo for Smokeless Tobacco Cessation

Buy Article:

$39.00 plus tax (Refund Policy)

Abstract:

Objective: To evaluate the potential efficacy of bupropion sustained release when used in combination with minimal counseling for moist snuff cessation in males. Methods: A double-blind, placebo-controlled 3-month trial. The active treatment group (n=35) received bupropion SR at 150 mg/qd day for the first 3 days, then beginning day 4 through day 49 (7 weeks) 150 mg/ b.i.d. The placebo group (n=35) received 1 tablet qd for 3 days and beginning day 4 through day 49, 1 tablet/b.i.d. Results: Bupropion 300 mg/day (150 b.i.d.) produced significantly higher quit rates for smokeless tobacco cessation at the end of treatment (7 weeks) than placebo (p=0.04) with an OR of 2.73. Conclusion: Bupropion SR appears to be effective for smokeless tobacco cessation.

Document Type: Research Article

DOI: http://dx.doi.org/10.5993/AJHB.26.5.7

Affiliations: 1: Addiction and Psychiatric Medicine Research, Department of Behavioral Medicine & Psychiatry, West Virginia University School of Medicine, Morgantown, WV. 2: Department of Community Medicine, West Virginia University School of Medicine, Morgantown, WV.

Publication date: September 1, 2002

More about this publication?
  • The American Journal of Health Behavior seeks to improve the quality of life through multidisciplinary health efforts in fostering a better understanding of the multidimensional nature of both individuals and social systems as they relate to health behaviors.

    The Journal aims to provide a comprehensive understanding of the impact of personal attributes, personality characteristics, behavior patterns, social structure, and processes on health maintenance, health restoration, and health improvement; to disseminate knowledge of holistic, multidisciplinary approaches to designing and implementing effective health programs; and to showcase health behavior analysis skills that have been proven to affect health improvement and recovery.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Review Board
  • Reprints and Permissions
  • ingentaconnect is not responsible for the content or availability of external websites
png/ajhb/2002/00000026/00000005/art00007
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more